Tariquidar is a potent third-generation anthranilic acid derivative that functions as a P-glycoprotein inhibitor, primarily researched for its ability to reverse multidrug resistance in the treatment of… Read more
Tariquidar is a potent third-generation anthranilic acid derivative that functions as a P-glycoprotein inhibitor, primarily researched for its ability to reverse multidrug resistance in the treatment of ovarian, lung, and breast cancers. Because clinical efficacy relies on precise drug characterization, analytical laboratories require high-quality materials to ensure rigorous quality control and method validation. This category provides essential reference standards for the Tariquidar active pharmaceutical ingredient, alongside its identified process and degradation impurities, metabolites, and stable isotope-labelled compounds. These materials are critical for accurate impurity profiling and quantitative analysis, enabling researchers to detect, identify, and quantify trace components throughout the drug development lifecycle. By utilizing these specialized reference materials, pharmaceutical scientists can maintain compliance with stringent regulatory requirements and ensure the integrity of their analytical testing protocols for this complex chemotherapeutic agent.